<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04091048</url>
  </required_header>
  <id_info>
    <org_study_id>MDT18051EVR008</org_study_id>
    <nct_id>NCT04091048</nct_id>
  </id_info>
  <brief_title>Optimize PRO Study</brief_title>
  <official_title>Optimize PRO Transcatheter Aortic Valve Replacement Post Market Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Cardiovascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Cardiovascular</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect clinical evidence on valve performance and procedural
      outcomes associated with an &quot;optimized&quot; TAVR care pathway and using the Evolut™ PRO and
      Evolut™ PRO+ device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a post market, multi-center, prospective, non-randomized study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 16, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause mortality or all-stroke at 30 days.</measure>
    <time_frame>30 days post procedure</time_frame>
    <description>All-cause mortality or all-stroke at 30 days.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Median days from index procedure to discharge</measure>
    <time_frame>Through discharge up to 7 days post index procedure.</time_frame>
    <description>Median days from index procedure to discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AR</measure>
    <time_frame>Through discharge up to 7 days post index procedure.</time_frame>
    <description>Percentage of subjects with ≥ moderate aortic regurgitation (AR) at discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of pacemaker implant for new onset or worsening conduction disturbance at 30 days</measure>
    <time_frame>30 days</time_frame>
    <description>Rate of pacemaker implant for new onset or worsening conduction disturbance at 30 days</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Hospital re-admission rates</measure>
    <time_frame>30-day and 1-year</time_frame>
    <description>30-day and 1-year hospital re-admission rates</description>
  </other_outcome>
  <other_outcome>
    <measure>All-cause mortality or all-stroke</measure>
    <time_frame>1-year</time_frame>
    <description>1-year composite of all-cause mortality or all-stroke</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Symptomatic Aortic Stenosis</condition>
  <arm_group>
    <arm_group_label>Primary Cohort</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Evolut™ PRO and Evolut™ PRO+ System</intervention_name>
    <description>Aortic valve replacement</description>
    <arm_group_label>Primary Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The study population includes patients with symptomatic native aortic valve stenosis that
        necessitates valve replacement who meet the criteria for on-label use of the Evolut™ PRO or
        Evolut™ PRO+ system in accordance with Instructions for Use and local regulations.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acceptable candidate for treatment with the Evolut™ PRO or Evolut™ PRO+ system in
             accordance with the Instructions for Use and local regulations;

          -  Subject is symptomatic from his/her aortic valve stenosis, as demonstrated by New York
             Heart Association (NYHA) Functional Class II or greater;

          -  Subject and the treating physician agree that the subject will return for all required
             post procedure follow-up visits;

          -  Anatomically suitable for transfemoral TAVR with the Medtronic TAVR system;

          -  Subject meets the legal minimum age to provide Informed Consent based on local
             regulatory requirements.

        Exclusion Criteria:

          -  Contraindicated for treatment with the Evolut™ PRO or Evolut™ PRO+ system in
             accordance with the Instructions for Use

          -  Anatomically not suitable for the Evolut™ PRO or Evolut™ PRO+ system;

          -  Any percutaneous coronary or peripheral interventional procedure performed within 30
             days prior to enrollment;

          -  Reduced ventricular function with left ventricular ejection fraction (LVEF) &lt;35% as
             measured by resting echocardiogram;

          -  Previous aortic valve replacement;

          -  Frailty assessments identify:

               -  Subject is &lt;80 years of age and three or more of the following apply; OR subject
                  is &gt; 80 years of age and two or more of the following apply

                    -  Wheelchair bound

                    -  Resides in an institutional care facility (e.g. nursing home, skilled care
                       center)

                    -  Body Mass Index &lt;20kg/m2

                    -  Grip strength &lt;16kg

                    -  Katz Index score ≤4

                    -  Albumin &lt;3.5 g/dL

          -  Bicuspid valve verified;

          -  Aortic root angulation (angle between plane of aortic valve annulus and horizontal
             plane/vertebrae) &gt; 70°.

          -  Implanted with pacemaker or ICD;

          -  Prohibitive left ventricular outflow tract calcification;

          -  Estimated life expectancy of less than 12 months due to associated non- cardiac
             co-morbid conditions;

          -  Other medical, social, or psychological conditions that in the opinion of the
             Investigator precludes the subject from appropriate consent or adherence to the
             protocol required follow-up exams;

          -  Currently participating in an investigational drug or another device trial (excluding
             registries);

          -  Need for emergency surgery for any reason.

          -  Subject is less than legal age of consent, legally incompetent, or otherwise
             vulnerable*.

               -  Notes: Vulnerable subjects include individuals whose willingness to volunteer in
                  a clinical investigation could be unduly influenced by the expectation, whether
                  justified or not, of benefits associated with participation or of retaliatory
                  response from senior members of a hierarchy in case of refusal to participate.
                  EXAMPLE Individuals with lack of or loss of autonomy due to immaturity or through
                  mental disability, persons in nursing homes, children, impoverished persons,
                  subjects in emergency situations, ethnic minority groups, homeless persons,
                  nomads, refugees, and those incapable of giving informed consent. Other
                  vulnerable subjects include, for example, members of a group with a hierarchical
                  structure such as university students, subordinate hospital and laboratory
                  personnel, employees of the sponsor, members of the armed forces, and persons
                  kept in detention.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Yakubov, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>OhioHealth</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kendra Grubb, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Emory University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Josep Rodés-Cabau, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Laval University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Suneet Mittal, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Valley Health System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tamim Nazif, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Columbia - New York Presbyterian</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Hemal Gada, MD</last_name>
    <role>Study Chair</role>
    <affiliation>UPMC Pinnacle</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy Corrigan</last_name>
    <phone>763-514-4000</phone>
    <email>rs.optimizedpro@medtronic.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yanping Chang</last_name>
    <phone>763-514-4000</phone>
    <email>rs.optimizedpro@medtronic.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Morton Plant Hospital</name>
      <address>
        <city>Clearwater</city>
        <state>Florida</state>
        <zip>33756</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Fisher</last_name>
    </contact>
    <investigator>
      <last_name>Lang Lin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joshua Rovin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University Hospital</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Charles</last_name>
    </contact>
    <investigator>
      <last_name>Kendra Grubb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adam Greenbaum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jessica Oakley</last_name>
    </contact>
    <investigator>
      <last_name>Stan Chetcuti, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Deeb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spectrum Health</name>
      <address>
        <city>Grand Rapids</city>
        <state>Michigan</state>
        <zip>49503</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Helm</last_name>
    </contact>
    <investigator>
      <last_name>William Merhi, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>John Heiser, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emily Schwindt</last_name>
    </contact>
    <investigator>
      <last_name>Andrew Goldsweig, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Valley Hospital</name>
      <address>
        <city>Ridgewood</city>
        <state>New Jersey</state>
        <zip>07450</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly Michel</last_name>
    </contact>
    <investigator>
      <last_name>Sean Wilson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mariano Brizzio, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NYU Langone Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephanie Gaudio</last_name>
    </contact>
    <investigator>
      <last_name>Mathew Williams, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cezar Staniloae, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New York Presbyterian - Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rosa Lazarte</last_name>
    </contact>
    <investigator>
      <last_name>Tamim Nazif, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stony Brook University Hospital</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruth Tenzler Stein</last_name>
    </contact>
    <investigator>
      <last_name>Robert Pyo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Bilfinger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ohio Health Research Institute</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43214</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katy Monin</last_name>
    </contact>
    <investigator>
      <last_name>Steven Yakubov, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Lehigh Valley Hospital - Cedar Crest</name>
      <address>
        <city>Allentown</city>
        <state>Pennsylvania</state>
        <zip>18103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristen Cornell</last_name>
    </contact>
    <investigator>
      <last_name>Nainesh Patel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Timothy Misselbeck, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>UPMC Pinnacle Harrisburg</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Courtney Rodgers</last_name>
    </contact>
    <investigator>
      <last_name>Hemal Gada, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracy Spirk</last_name>
    </contact>
    <investigator>
      <last_name>Ramzi Khalil, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Allegheny General Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tracy Spirk</last_name>
    </contact>
    <investigator>
      <last_name>Ramzi Khalil, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>York Hospital</name>
      <address>
        <city>York</city>
        <state>Pennsylvania</state>
        <zip>17403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elayne Grim</last_name>
    </contact>
    <investigator>
      <last_name>James Harvey, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Burlingame, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Laval University Institute of Cardiology and Respirology of Quebec</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire Gibrat</last_name>
    </contact>
    <investigator>
      <last_name>Josep Rodes-Cabau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>September 12, 2019</study_first_submitted>
  <study_first_submitted_qc>September 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2019</study_first_posted>
  <last_update_submitted>May 13, 2020</last_update_submitted>
  <last_update_submitted_qc>May 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

